CMS Announces Part D Enhanced Medication Therapy Management Model
Posted on Monday, September 28, 2015 2:25 PM
Today, the CMS Center for Medicare and Medicaid Innovation (CMMI) announced a model to test strategies to improve medication use among Medicare beneficiaries enrolled in Part D. Medication therapy management can improve healthcare and outcomes for patients, and has the potential to lower overall healthcare costs.
The Part D Enhanced Medication Therapy Management (Enhanced MTM) model will assess whether providing selected Medicare Prescription Drug Plans (PDPs) with additional incentives and flexibilities to design and implement innovative programs will better achieve the overall goals for MTM program, including:
- improving compliance with medication protocols, including high-cost drugs, ensuring that beneficiaries get the medications they need, and they are used properly;
- reducing medication-related problems, such as duplicative or harmful prescription drugs, or suboptimal treatments;
- increasing patients’ knowledge of their medications to better achieve their or their prescribers’ goals of therapy; and
- improving communication among prescribers, pharmacists, caregivers and patients.
The Enhanced MTM model test will begin January 1, 2017, with a five-year performance period.
to read more from CMS.